Ras induction of superoxide activates ERK-dependent angiogenic transcription factor HIF-1alpha and VEGF-A expression in shock wave-stimulated osteoblasts
- PMID:14681237
- DOI: 10.1074/jbc.M308013200
Ras induction of superoxide activates ERK-dependent angiogenic transcription factor HIF-1alpha and VEGF-A expression in shock wave-stimulated osteoblasts
Abstract
Vascular endothelial growth factor (VEGF) released by osteoblasts plays an important role in angiogenesis and endochondral ossification during bone formation. In animal studies, we have reported that shock waves (SW) can promote osteogenic differentiation of mesenchymal stem cells through superoxide-mediated signal transduction (Wang, F. S., Wang, C. J., Sheen-Chen, S. M., Kuo, Y. R., Chen, R. F., and Yang, K. D. (2002) J. Biol. Chem. 277, 10931-10937) and vascularization of the bone-tendon junction. Here, we found that SW elevation of VEGF-A expression in human osteoblasts to be mediated by Ras-induced superoxide and ERK-dependent HIF-1alpha activation. SW treatment (0.16 mJ/mm(2), 1 Hz, 500 impulses) rapidly activated Ras protein (15 min) and Rac1 protein (30 min) and increased superoxide production in 30 min and VEGF mRNA expression in 6 h. Early scavenging of superoxide, but not nitric oxide, peroxide hydrogen, or prostaglandin E(2), reduced SW-augmented VEGF-A levels. Inhibition of superoxide production by diphenyliodonium, an NADPH oxidase inhibitor, was found to suppress VEGF-A expression. Transfection of osteoblasts with a dominant negative (S17N) Ras mutant abrogated the SW enhancement of Rac1 activation, superoxide synthesis, and VEGF expression. Further studies demonstrated that SW significantly promoted ERK activation in 1 h and HIF-1alpha phosphorylation and HIF-1alpha binding to VEGF promoter in 3 h. In support of the observation that superoxide mediated the SW-induced ERK activation and HIF-1alpha transactivation, we further demonstrated that scavenging of superoxide by superoxide dismutase and inhibition of ERK activity by PD98059 decreased HIF-1alpha activation and VEGF-A levels. Moreover, culture medium harvested from SW-treated osteoblasts increased vessel number of chick chorioallantoic membrane. Superoxide dismutase pretreatment and anti-VEGF-A antibody neutralization reduced the promoting effect of conditioned medium on angiogenesis. Thus, modulation of redox reaction by SW may have some positive effect on angiogenesis during bone regeneration.
Similar articles
- Nitric oxide mediates ultrasound-induced hypoxia-inducible factor-1alpha activation and vascular endothelial growth factor-A expression in human osteoblasts.Wang FS, Kuo YR, Wang CJ, Yang KD, Chang PR, Huang YT, Huang HC, Sun YC, Yang YJ, Chen YJ.Wang FS, et al.Bone. 2004 Jul;35(1):114-23. doi: 10.1016/j.bone.2004.02.012.Bone. 2004.PMID:15207747
- Superoxide mediates shock wave induction of ERK-dependent osteogenic transcription factor (CBFA1) and mesenchymal cell differentiation toward osteoprogenitors.Wang FS, Wang CJ, Sheen-Chen SM, Kuo YR, Chen RF, Yang KD.Wang FS, et al.J Biol Chem. 2002 Mar 29;277(13):10931-7. doi: 10.1074/jbc.M104587200. Epub 2002 Jan 9.J Biol Chem. 2002.PMID:11784711
- Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line.Liu XH, Kirschenbaum A, Lu M, Yao S, Dosoretz A, Holland JF, Levine AC.Liu XH, et al.J Biol Chem. 2002 Dec 20;277(51):50081-6. doi: 10.1074/jbc.M201095200. Epub 2002 Oct 24.J Biol Chem. 2002.PMID:12401798
- Role of HIF-1alpha in skeletal development.Wan C, Shao J, Gilbert SR, Riddle RC, Long F, Johnson RS, Schipani E, Clemens TL.Wan C, et al.Ann N Y Acad Sci. 2010 Mar;1192:322-6. doi: 10.1111/j.1749-6632.2009.05238.x.Ann N Y Acad Sci. 2010.PMID:20392254Free PMC article.Review.
- Role of hydrogen sulphide in physiological and pathological angiogenesis.Zhang YX, Jing MR, Cai CB, Zhu SG, Zhang CJ, Wang QM, Zhai YK, Ji XY, Wu DD.Zhang YX, et al.Cell Prolif. 2023 Mar;56(3):e13374. doi: 10.1111/cpr.13374. Epub 2022 Dec 7.Cell Prolif. 2023.PMID:36478328Free PMC article.Review.
Cited by
- Rac1, A Potential Target for Tumor Therapy.Liang J, Oyang L, Rao S, Han Y, Luo X, Yi P, Lin J, Xia L, Hu J, Tan S, Tang L, Pan Q, Tang Y, Zhou Y, Liao Q.Liang J, et al.Front Oncol. 2021 May 17;11:674426. doi: 10.3389/fonc.2021.674426. eCollection 2021.Front Oncol. 2021.PMID:34079763Free PMC article.Review.
- Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9.Liang J, Liu Q, Xia L, Lin J, Oyang L, Tan S, Peng Q, Jiang X, Xu X, Wu N, Tang Y, Su M, Luo X, Yang Y, Liao Q, Zhou Y.Liang J, et al.Cancer Sci. 2023 Mar;114(3):822-836. doi: 10.1111/cas.15652. Epub 2022 Nov 29.Cancer Sci. 2023.PMID:36369902Free PMC article.
- In Vivo Modulation of Angiogenesis and Immune Response on a Collagen Matrix via Extracorporeal Shockwaves.Heimes D, Wiesmann N, Eckrich J, Brieger J, Mattyasovszky S, Proff P, Weber M, Deschner J, Al-Nawas B, Kämmerer PW.Heimes D, et al.Int J Mol Sci. 2020 Oct 14;21(20):7574. doi: 10.3390/ijms21207574.Int J Mol Sci. 2020.PMID:33066403Free PMC article.
- Emerging drugs for the treatment of diabetic ulcers.Tecilazich F, Dinh TL, Veves A.Tecilazich F, et al.Expert Opin Emerg Drugs. 2013 Jun;18(2):207-17. doi: 10.1517/14728214.2013.802305. Epub 2013 May 21.Expert Opin Emerg Drugs. 2013.PMID:23687931Free PMC article.Review.
- A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib.Santangelo A, Rossato M, Lombardi G, Benfatto S, Lavezzari D, De Salvo GL, Indraccolo S, Dechecchi MC, Prandini P, Gambari R, Scapoli C, Di Gennaro G, Caccese M, Eoli M, Rudà R, Brandes AA, Ibrahim T, Rizzato S, Lolli I, Lippi G, Delledonne M, Zagonel V, Cabrini G.Santangelo A, et al.Neuro Oncol. 2021 Feb 25;23(2):264-276. doi: 10.1093/neuonc/noaa156.Neuro Oncol. 2021.PMID:32661549Free PMC article.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous